Looking for a publishing partner?
Go with the expert. For over 30 years, Clinical Therapeutics has been a leading journal voice for recent developments in drug therapy and pharmaceutical economics, serving an international audience of scientists and clinicians in a variety of research, academic, and clinical practice settings.
Reap the rewards. As an author, Clinical Therapeutics affords you and your paper an unmatched array of benefits including:
- high-quality, rapid peer review;
- professional editorial staff whose goal is to guide you through the submission, review, and revision processes;
- rapid publication of your paper online, within 20 business days after acceptance;
- indexing by all major biomedical abstracting databases;
- strong annual and 5-year impact factors;
- inclusion in Science Direct, serving over 11 million users.
Get results. Submit your paper to Clinical Therapeutics online @ ees.elsevier.com/clinther
Issue Highlights
Pharmacotherapy
Review Article
Utility of Interferon-? Release Assay Results to Monitor Anti-Tubercular Treatment in Adults and ChildrenPharmaceutical Economics & Health Policy
Original Research
Failure to Intensify Hypertension Therapy After Rejected Aliskiren Claims
-
Pharmacokinetic Profile of Beclomethasone Dipropionate Hydrofluoroalkane After Intranasal Administration Versus Oral Inhalation in Healthy Subjects: Results of a Single-Dose, Randomized, Open-Label, 3-Period Crossover Study24 May 2012
-
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review21 May 2012
-
Efficacy and Tolerability of Once-Daily Oral Fimasartan 20 to 240 mg/d in Korean Patients with Hypertension: Findings from Two Phase II, Randomized, Double-Blind, Placebo-Controlled Studies21 May 2012
-
Long-Term Effects of Adding Exenatide to a Regimen of Metformin and/or Sulfonylurea in Type 2 Diabetes: An Uncontrolled, Open-Label Trial in Hungary18 May 2012
-
Costs and Clinical Outcomes Associated with Use of Ranolazine for Treatment of Angina18 May 2012
